Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Petco Health & Wellness Company (WOOF) Cash & Equivalents (2021 - 2026)

Petco Health & Wellness Company's Cash & Equivalents history spans 6 years, with the latest figure at $256.7 million for Q1 2026.

  • For Q1 2026, Cash & Equivalents rose 54.89% year-over-year to $256.7 million; the TTM value through Jan 2026 reached $256.7 million, up 54.89%, while the annual FY2026 figure was $256.7 million, 54.89% up from the prior year.
  • Cash & Equivalents reached $256.7 million in Q1 2026 per WOOF's latest filing, up from $237.4 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $256.7 million in Q1 2026 to a low of $89.7 million in Q2 2024.
  • Average Cash & Equivalents over 5 years is $163.6 million, with a median of $148.9 million recorded in 2023.
  • Peak YoY movement for Cash & Equivalents: crashed 39.76% in 2024, then surged 103.48% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $148.7 million in 2022, then fell by 6.02% to $139.8 million in 2023, then decreased by 16.53% to $116.7 million in 2024, then soared by 103.48% to $237.4 million in 2025, then rose by 8.14% to $256.7 million in 2026.
  • Per Business Quant, the three most recent readings for WOOF's Cash & Equivalents are $256.7 million (Q1 2026), $237.4 million (Q4 2025), and $188.7 million (Q3 2025).